Zimulti (Rimonabant) is a new miraculous multifunctional diet pill:
Zimulti (Rimonabant) is the first in a new class of therapeutic agents called Cannabinoid-1 Receptor Blockers (CB1).
Zimulti acts by selectively blocking CB1 receptors found in the brain and in peripheral organs important in glucose and lipid (or fat) metabolism, including adipose tissue, the liver, gastrointestinal tract and muscle1.
Zimulti switches off the same brain circuits that make people hungry when they smoke cannabis.
Zimulti is used complementary to diet and exercise to treat obese or overweight patients who suffer from Type 2 diabetes and abnormal levels of fat in the blood.
Sanofi argues that Zimulti can also prevent the risk of cardiovascular disease.
Zimulti has been studied by sanofi-aventis as an aid to smoking cessation based on studies for up to one year in over 6,500 smokers motivated to quit smoking.
fda zimulti rejected india zimulti acomplia rimonabant acomplia rimonabant zimulti acomplia zimulti fda zimulti order zimulti acomplia zimulti blog zimulti sales zimulti and fda medical news zimulti zimulti and advisory and committee find info on zimulti zimulti cheap buying zimulti zimulti rimonabant diet pill zimulti acomplia and smoking zimulti acomplia online acomplia or rimonabant or zimulti fda drug approvals zimulti zimulti legalization purchase zimulti acomplia rimonabant purchase zimulti acomplia zimulti legal zimulti available in the united states sanofi-aventis zimulti buy zimulti zimulti acomplia zimulti drug purchase generic zimulti acomplia rimonabant what is zimulti